Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.2 (
topoisomerase
)
9,166
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The human
KIN17
protein is a chromatin-associated protein involved in DNA replication. Certain tumor cell lines overproduce
KIN17
protein. Among 16 cell lines, the highest
KIN17
protein level was observed in H1299 non-small cell lung cancer cells, whereas the lowest was detected in MeWo melanoma cells. Cells displaying higher
KIN17
protein levels exhibited elevated RPA70 protein contents. High
KIN17
protein levels may be a consequence of the tumorigenic phenotype or a prerequisite for tumor progression. Twenty-four hours after exposure to ionizing radiation, after the completion of DNA repair, a co-induction of chromatin-bound
KIN17
and RPA70 proteins was detected. Etoposide, an inhibitor of
topoisomerase
II generating double-strand breaks, triggered the concentration of
KIN17
into punctuate intranuclear foci.
KIN17
may be associated with unrepaired DNA sites. Flow cytometry analysis revealed that 48 h after transfection the uppermost
KIN17
-positive RKO cells shifted in the cell cycle toward higher DNA content, suggesting that
KIN17
protein induced defects in chromatin conformation. Cells displaying reduced levels of
KIN17
transcript exhibited a sixfold increased radiosensitivity at 2 Gy. The
KIN17
protein may be a component of the DNA replication machinery that participates in the cellular response to unrepaired DSBs, and an impaired
KIN17
pathway leads to an increased sensitivity to ionizing radiation.
...
PMID:Depletion of KIN17, a human DNA replication protein, increases the radiosensitivity of RKO cells. 1275 57